Antiperinuclear factor isotypes in rheumatoid arthritis
Muñoz-Fernãndez, S.; Alvarez-Doforno, R.; Fontán, G.; Gijón, J.
Clinical and Experimental Rheumatology 13(4): 529; Author Reply 530-1
1995
ISSN/ISBN: 0392-856X PMID: 7586792 Document Number: 452960
Document emailed within 1 workday
Related Documents
Tanaka, S.; Watanabe, N.; Nishioka, K.; Hosoda, K. 1986: Rheumatoid factor isotypes and immune complex isotypes in juvenile rheumatoid arthritis Ryumachi 26(4): 259-269Feltkamp, T.E.; Berthelot, J.M.; Boerbooms, A.M.; Geertzen, H.G.; Hoet, R.; De Keyser, F.; van Venrooij, W.J.; Verbruggen, G.; Veys, E.M.; Youinou, P. 1993: Interlaboratory variability of the antiperinuclear factor (APF) test for rheumatoid arthritis Clinical and Experimental Rheumatology 11(1): 57-59
Sihvonen, S.; Korpela, M.; Mustila, A.; Mustonen, J. 2005: The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis Journal of Rheumatology 32(11): 2089-2094
Kim, D.-A.; Jearn, L.-H.; Kim, T.-Y. 2007: Antiperinuclear factor test is more useful than anti-Sa assay when used with anti-cyclic citrullinated peptide test in diagnosis of rheumatoid arthritis Journal of Rheumatology 34(9): 1944-1945
Saraux, A.; Valls, I.; Voisin, V.; Koreichi, A.; Baron, D.; Youinou, P.; Le Goff, P. 1995: How useful are tests for rheumatoid factors, antiperinuclear factors, antikeratin antibody, and the HLA DR4 antigen for the diagnosis of rheumatoid arthritis? Revue du Rhumatisme 62(1): 16-20
Youinou, P.; Le Goff, P.; Miossec, P.; Moineau, M.P.; Ferec, C. 1983: Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis Zeitschrift für Rheumatologie 42(1): 36-39
Grieble, H.; Bach, G.; Anderson, T.; Zschocke, R. 1971: Standardization of the latex fixation test for the demonstration of the rheumatoid factor. 3. Nature of the rheumatoid factor in normal serum, in serum of patients with rheumatoid arthritis, and in serum of the aged Acta Biologica et Medica Germanica 26(1): 185-191
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
De Pádua, P.M.; Antunes, L.J. 1973: Latex-seronegative rheumatoid arthritis. Demonstration of the rheumatoid factor: chromatography and dialysis Amb: Revista da Associacao Medica Brasileira 19(10): 389-390
Goodson, N.J.; Farragher, T.M.; Symmons, D.P.M. 2008: Rheumatoid factor, smoking, and disease severity: associations with mortality in rheumatoid arthritis Journal of Rheumatology 35(6): 945-949
Vlak, T.; Jajić, I. 1992: The effect of gold salts on rheumatoid factor dynamics in patients with rheumatoid arthritis Reumatizam 39(1): 11-13
Moore, F.L.; Osborn, T.G. 1986: 19S IgM rheumatoid factor plaque forming cells in a five-year-old patient with juvenile rheumatoid arthritis Journal of Rheumatology 13(4): 829-830
Kaipiainen-Seppanen, O.; Kautiainen, H. 2006: Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980-2000 Journal of rheumatology 33(11): 2132-2138
Kuru, O.; Bilgici, A.; Birinci, A.; Ulusoy, H.; Durupinar, B. 2009: Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis Bratislavske Lekarske Listy 110(10): 650-654
Al-Azem, I.; Fernandez-Madrid, F.; Long, P.M.; Wooley, P.H. 1992: The immunoregulation of rheumatoid factor by the CD8 T lymphocyte subset in rheumatoid arthritis Journal of Rheumatology 19(9): 1337-1341
Chatpar, P.C.; Muller, D.; Gruber, B.; Kaplan, A.P.; Gorevic, P.D. 1986: Prevalence of IgE rheumatoid factor (IgE RF) in mixed cryoglobulinemia and rheumatoid arthritis Clinical and Experimental Rheumatology 4(4): 313-317
Gonzalez, A.; Icen, M.; Kremers, H.Maradit.; Crowson, C.S.; Davis, J.M.; Therneau, T.M.; Roger, V.L.; Gabriel, S.E. 2008: Mortality trends in rheumatoid arthritis: the role of rheumatoid factor Journal of Rheumatology 35(6): 1009-1014
Elson, C.J.; Carter, S.D.; Cottrell, B.J.; Scott, D.G.; Bacon, P.A.; Wallington, T.B. 1985: Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis Clinical and Experimental Immunology 59(2): 285-292
Nonaka, S.; Yasuda, M.; Nobunaga, M. 1993: In vitro IgM rheumatoid factor production by peripheral blood mononuclear cells from patients with seronegative rheumatoid arthritis Journal of Rheumatology 20(9): 1478-1484
Kitani, A.; Hara, M.; Hirose, T.; Norioka, K.; Hirose, W.; Harigai, M.; Suzuki, K.; Kawagoe, M.; Shinmei, M.; Nakamura, H. 1987: Synovial fluids from patients with rheumatoid arthritis possessed B cell differentiation activity contributing to synthesis of rheumatoid factor in vitro Journal of Rheumatology 14(5): 873-879